RCR. Cesnjevar

R. Cesnjevar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


R. Cesnjevar has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neonatal myocardium is more sensitive to perioperative ischemic damage than myocardium of elder children

    by J. Suc, A. Purbojo, A. Rüffer, A. Koch, K.P. Eberle, F. Münch, R. Cesnjevar

    Objectives: Determination of differences in post-ischemic myocardial performance between neonatal myocardium and infant cardiomyocytes following corrective biventricular repair in selected standard procedures according to patient age. Methods: Observational clinical, hemodynamic and laboratory data of all patients operated between 01/2010 and 12/2012 were transferred to a hospital registry and analyzed using a standard protocol. Patients with TGA (IVS and VSD, n = 22) undergoing neonatal repair and patients scheduled for VSD repair (single and multiple, n = 53) entered the study and were closely compared regarding laboratory changes and hemodynamic variation. Standard crystalloid cardioplegia was used for myocardial protection in both groups (Custodiol®; 30 ml/kg) initially and a dose repetition after 60 minutes cross clamping. Results: There was no operative mortality. Patient groups differed significantly by age, Aristotle-score and cross clamp time per definition. TGA-patients were more volume-loaded than VSD-patients (NT-ProBNP: 13415 ± 2528 pg/ml vs 1516 ± 414 pg/ml, p < 0.01). Troponin-I, Troponin-T and CK-MB immediately postCPB were significantly higher in group TGA (TN-I: 11,4 ± 2,1 ng/l vs 7,3 ± 1,0 ng/l, p < 0,05; TN-T: 11,50 ± 1,8 ng/l vs 6,4 ± 1,0 ng/l, p < 0,05 and CK-MB: 275,2 ± 27,4 U/l vs 174,0 ± 16,0 U/l, p < 0,01). Perioperative myocardial trauma resulted in lowered Cardiac-Indices post-CPB for TGA-patients compared to VSD-patients (CI: 2,0 ± 0,37 l/min/m2 vs 3,1 ± 0,44 l/min/m2, p < 0.05). Conclusions: Neonatal cardiomyocytes react differently to ischemic perioperative stress than more mature myocardium displayed by higher CK-MB and Troponin post-surgical repair. Perioperative myocardial damage resulted in lowered hemodynamic performance which is partly related to an exceptional preoperative volume load, which might explain the higher perioperative risk of neonatal corrective repairs.

  • Performance of stented biological valves for pulmonary valve replacement

    by C. Buchholz, A.M. Koch, A. Purbojo, O. Toka, S. Dittrich, R.A. Cesnjevar, A. Rüffer

    Objective: Our experience with isolated stented biological valves (SBV) in pulmonary position without conduit was retrospectively assessed. Methods: Thirty-nine stented biological valves (17 Edwards SAV; 12 Edwards CEP; 4 Sorin Mitroflow; 4 Sorin SOPRANO; 4 Sorin MORE) were implanted between 2000 and 2010. Median valve size was 23 mm (range, 19-27); median patients age and weight were 20.1 years (range, 5-72) and 60 kg (range, 14-110), respectively. Thirty-five patients (90%) had previous cardiac surgery. Main diagnoses were tetralogy of Fallot (54%) and pulmonary atresia (18%). Results: There was no early mortality. Follow-up was complete with a mean duration of 8.9 ± 3.8 years. Two patients died late after 5.8 and 6.1 years, respectively, both not SBV related. In 12 patients (31%) SBV has been replaced by surgery (n = 9) or intervention (n = 3). Reason for SBV failure were valve stenosis (n = 9) or stenosis and insufficiency (n = 3). Additionally, 2 RVOT-aneurysms and 1 endocarditis were diagnosed. Freedom from SBV-replacement by surgery or intervention was 95%, 84% and 77% after 3, 5 and 10 years, respectively. Risk factors for SBV-replacement by univariate analysis were valve size ≤21 mm (p = 0.050), lower age (p < 0.01) and pulmonary atresia (p = 0.006). The only independent risk factor by cox-regression analysis was lower age (hazard ratio: 0.87, confidence interval: 0.76-0.99; p = 0.036). Conclusion: SBV in pulmonary position revealed encouraging long-term results. Younger patient age and pulmonary atresia seem to be associated with higher risk of SBV failure.

  • Body-Overload an interstitiellem Natrium als Ursache für therapierefraktäre Ödeme in Failing Fontan Patienten

    by J Moosmann, C Kopp, A Cavallaro, M Weyand, M Uder, R Cesnjevar, S Dittrich, J Titze, O Toka

    Grundlage: Serum-Hyponatriämie und interstitielle Hypernatriämie sind etablierte negative Prädiktoren bei der Herzinsuffizienz. Bis dato gibt es dazu keine Daten für Fontan Patienten. Methodik: Komplexes Monitoring des Salz-Wasser-Haushaltes vor und während der Therapie mit Tolvaptan (ADH-Blocker) mit serieller Quantifizierung des interstitiellen Wasser und Natrium Gehalts mittels experimenteller 23Na-MRT-Bildgebung. Analoge Aktivitätsbestimmungen von Renin, Angiotensin, Aldosteron und Copeptin (ADH-Äquivalent), sowie Na-Messungen in Serum und Urin. Ergebnisse: Die 23Na-MRT Messung zeigte erstmals bei Fontan Patienten eine signifikante Na+-Überladung in der Muskulatur sowie eine hochsignifikante Anreicherung in der Haut. Unter Tolvaptan-Therapie konnte nicht nur eine Reduktion des Gewichts (max. 3,6 kg = 7% des KG) in Form von freiem interstitiellem Wasser, sondern auch eine signifikante Reduktion (bis zur Normalisierung) des Natriums in der Muskulatur (um 12,2%) und der Haut (um 26,9%) erreicht werden. Analog zeigte sich eine Aktivitätsminderung im entgleisten RAAS Systems. Schlussfolgerungen: Failing Fontan Patienten weisen trotz Serum-Hyponatriämie einen erheblichen interstitiellen Na-Overload auf, der mittels 23Na-MRT quantifiziert und durch einen bis dato nicht beschriebenen saluretischen Effekt von Tolvaptan normalisiert werden konnte. Prognostische und therapeutische Implikationen müssen diskutiert und untersucht werden.

  • Congenital Coronary Artery Fistula Draining Into the Right Ventricle: Successful Surgical Closure After Failed Transcatheter Coil Embolization

    by T. Strecker, L. Hakami, H. Singer, M. Weyand, R. Cesnjevar

    Coronary artery aneurysms and fistulae are very rare congenital anomalies. They occur in 0.2 - 0.4 % of all congenital heart diseases. In this article, we report a case of a four-year-old girl with a right coronary artery aneurysm and fistula draining into the right ventricle. Since the transcatheter coil embolization was not successful, surgical occlusion was considered in this case. We describe and discuss the handling of the fistula and the aneurysmatic enlargement of the proximal coronary artery.


  • Antegrade cerebral perfusion at higher temperatures is more neuroprotective than deep hypothermic circulatory arrest (DHCA) during aortic arch operations in young piglets

    by R Cesnjevar, T Seitz, P Mauser-Weber, T Palmaers, O Rörick, M Weyand

    Aims: Aortic-arch-operations in pediatric patients using continuous hypothermic low-flow-perfusion-techniques with antegrade cerebral flow have become very popular due to their neuroprotective potential. Modern protocols tend to increase the perfusion-temperature in order to simplify surgery, however a clear hypothermic border and the effectiveness of any subdiaphragmal perfusion via native collaterals are not defined. Methods: 26 male newborn piglets (10–15kg) underwent aortic-arch-surgery in general anaesthesia using either low-flow-perfusion via the innominate artery (group 1: 30ml/kg/min, 25°C, n=12) or conventional DHCA (group 2: 20°C, n=14). Cortical SSEP, carotid and subdiaphragmal blood flows where measured. Detection of neuron damage consisted of intermittent blood-sampling (NSE and S-100) and histologic examination of 5 different areas at the end of the experiment. Results: During low-flow-perfusion via the innominate artery only negligible flows of max. 1–3ml/min in the femoral arteries were detected, whereas right-carotid-artery-flow was doubled (group 1). S-100- and NSE-serum-levels did not differ in both groups. Cortical SSEP returned to preoperative values in all but two low-flow-animals. There was no return of SSEP in all piglets operated using DHCA (pConclusion: Low-flow-perfusion via the innominate artery provides superior functional neuroprotection compared to DHCA, despite higher tissue temperature. Quantitative neuron damage seems to be similar in both groups according to histologic examinations and the measurements of S-100 and NSE. Although collateral blood-flow via the subclavian artery and the circulosus willisii have often been suggested only “trickle-flow“ in the inguinal arteries was detectable.

  • Hämodynamische Effektivität hyperton-hyperonkotischer Kochsalzösungen bei Kindern nach herzchirurgischen Eingriffen

    by M. Schroth, C. Plank, U. Meißner, K. P. Eberle, R. Cesnjevar, M. Weyand, W. Rascher, J. Dötsch

    Einleitung: Hyperton-hyperonkotische Kochsalzlösungen (HHS) werden seit fast 2 Jahrzehnten zur Stabilisierung von Mikro- und Makrozirkulation bei Schockzuständen unterschiedlicher Ätiologie erfolgreich eingesetzt. Ziel der hier vorgestellten klinischen Studie war es, die hämodynamischen Effekte von HHS zum ersten Male bei Kindern, evaluiert in der frühen postoperativen Phase nach Eingriffen an der Herz-Lungen-Maschine, darzustellen. Patienten und Methodik: Fünfzig Kinder, die zur Korrektur entweder eines Vorhof- oder Ventrikelseptumdefektes unter Einsatz der Herz-Lungen-Maschine anstanden, wurden eingeschlossen. Unmittelbar nach erfolgtem Eingriff wurde auf der Kinder-Intensivstation eine hyperton-hyperonkotische Kochsalzlösung (7,2% NaCl mit 6% Hydroxyäthylstärke) oder, als Kontrolle, isotonische Kochsalzlösung infundiert. Mittels Thermodilutionsmessung wurden u.a. der Herzindex (HI), der Schlagvolumenindex (SVI), der systemische Gefäßwiderstandsindex (SVRI) sowie der extravaskuläre Lungenwasserindex (ELWI) vor und nach Applikation der Lösung bestimmt. Ergebnisse: In der HHS Gruppe zeigte sich ein hoch signifikanter Anstieg des HI von 3,6±0,26 auf 5,96±0,27 l/min/m2 direkt nach der Applikation (p2, pZusammenfassung: Anhand der hämodynamischen Daten der hier durchführten Studie kann HHS bei Kindern als mögliche Therapiestrategie eines Low-Cardiac-Output-Syndroms nach herzchirurgischen Eingriffen empfohlen werden. HHS stellen eine mögliche Therapieoption in der Prophylaxe bzw. in der Behandlung eines kapillären Lecksyndroms bei Kindern nach Eingriffen an der Herz-Lungen-Maschine dar. Die Applikation von HHS bei Kindern ist sicher.

  • Early results of complex mitral-valve-reconstruction in pediatric patients

    by R. Cesnjevar, L. Hakami, A. Reimann, P. Zartner, M. Weyand

    Objectives: Study-aim was the retrospective evaluation of results in mitral-valve-reconstruction (MVR) in the pediatric population without the use of prosthetic material. Material and Methods: Eleven patients (mean-age 4.5±1.5 years, range 0.2–14.7 years) underwent MVR between 01/2002 and 09/2004. Indications for surgery were mitral-stenosis (n=4; 36.7%), mitral-incompetence (n=5; 45.5%) or the combination of both (n=2, 18.2%). Three patients (27.3%) had previous operations. One patient required MVR after VSD-closure and two patients with Shone-complex after coarctation repair. All patients were repaired without the use of prosthetic material with different individually adopted surgical techniques like commissurotomy plus chordae-repair (n=4), leaflet repair (n=3), leaflet repair plus anuloplasty (n=2), simple anuloplasty (n=1) or comissurotomy plus excision of a supravalvar membrane (n=1). Results: There was no mortality or indication for reoperation. Stenosis improved significantly from grade 3.3±0.3 to 0.2±0.2; mitral-incompetence was diminished from grade 2.9±0.4 to 1.5±0.3. Comparison of intraoperative TEE and follow-up echocardiograms showed no relevant progression during follow-up. All patients are asymptomatic, LV-function was well presevered over a mean follow-up-period of 1.2±0.2 years. Conclusions: Mitral-valve-reconstruction avoiding the use of prosthetic material is always the first choice in growing pediatric patients. Most of the lesions are of complex anatomical origin and residual incompetence or stenosis after surgery are common. This is well accepted in order to preserve valvar growth potential without the need of anticoagulation in these young patients. Until now our results using an adopted approach to patients anatomy has given us good functional results so far, but reoperations will be inevitably necessary, hopefully in the adult age.

  • Does the additional use of heparin-coated extracorporeal circuits (ECC) optimize the effect of Modified Ultrafiltration (MUF) in pediatric perfusion?

    by F. Harig, R. Feyrer, A. Reimann, L. Hakami, E. Strasser, F. Münch, E. Vestweber-Wilmes, J. Bretzger, H. Singer, M. Weyand, et al.

    Objectives: Modified ultrafiltration (MUF) has been shown to exert beneficial effects on the coagulation system and the capillary leak after pediatric cardiac surgery using extracorporeal circulation (ECC). Aim of this study was to investigate if the additional use of heparin-coated circuits is a useful option for improving biocompatibility. Material and Methods: We randomized 28 children, using heparin-coated ECC- circuits in group A (n=14) and an uncoated equivalent set in group B (n=14). After congenital heart surgery, MUF was performed post ECC in a standardized fashion. Blood samples were analysed preoperatively, 10min, 30min, 1h and 48h after ECC by flow cytometric analysis (FACSort) using surface antigens CD62/CD41b (platelets) and CD45/CD14 (monocytes). Results: No significant difference could be found concerning mean age (20.6 mon vs. 21.6 mon), mean body weight (9.2kg vs. 8.4kg), mean ultrafiltration rate (9.1ml/kg vs. 11.4ml/kg), chest tube drainage, blood products, ICU stay and 30d survival. The percentage of CD62/CD41-positive platelets in group A (vs. B) increased up to 118% at 60' vs. 130% [p0.05]. Conclusions: Heparin-coating of ECC plus MUF leads to lower platelet activation. Monocyte markers (CD45/CD14) indicated a marked activation during ECC in both groups, additional heparin coating showed a better regeneration of monocyte markers in the late postoperative course indicating a beneficial additive effect.

  • Pediatric aortic arch repair on cardiopulmonary bypass beating heart - is it feasible?

    by M. Kondruweit, L. Hakami, R. Tandler, M. Weyand, R. Cesnjevar

    Objectives: The aim of this study was to investigate the feasibility of aortic arch corrections on cardiopulmonary bypass (CPB) using a beating-heart technique. Material and Methods: Ten children (age=0.1–209.4 months; mean=27.5 months) were operated on CPB beating heart between 5/02 and 9/04. Six children had intracardiac additional lesions (VSD/PFO: n=2; ASD: n=3; Aortic-valve lesion: n=1). Starting with conventional hypothermic CPB the arterial cannula was advanced to the brachiocephalic trunc and snared during arch repair. A separate pump was connected to a conventional cardioplegic needle in the ascending aorta to ensure coronary perfusion (ca. 10% of full CPB-flow). The left heart was vented via the right upper pulmonary vein. The ascending and descending aorta and the head and neck vessels were clamped. We performed low flow CPB with 20–30% of calculated flow. Adequate perfusion was monitored by intermittent serum lactate-level measurement, sufficient coronary supply by continuous ECG-registration. Additional cardiac defects were repaired under standard cardioplegic arrest (n=6; mean 25min). Results: All children survived, only one child showed ECG changes despite a higher flow on CPB so that cardioplegic arrest was performed. There was no persisting myocardial ischemia (post-OP troponin day 1=4.4 ng/ml±0.9) and no neurological morbidity, only mild inotropic support was needed. Postoperative echo showed an adequate size of the repaired aortic arch in all patients. Conclusions: Pedriatic aortic arch correction on CPB beating heart is technically feasible and safe. In more complex cardiac defects requiring long cross-clamping times this technique may lower operative morbidity and mortality.